| Drug Type AAV based gene therapy | 
| Synonyms AXO-AAV-FTD, AXO-AAV-TBD | 
| Target- | 
| Action- | 
| Mechanism RNA interference | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization | 
| Drug Highest PhasePendingPreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Amyotrophic Lateral Sclerosis | Preclinical | - | - | |
| Dementia | Preclinical | - | - | 





